Technological Focus Covetrus is heavily tech-enabled, utilizing a broad tech stack including SAP Hybris, Informatica, and Spring Boot, indicating a strong reliance on advanced digital solutions. This presents opportunities to offer complementary technology services, integration solutions, or innovative veterinary software that can enhance their existing infrastructure.

Expansion Opportunities Recent strategic moves, such as the agreement for Chewy to acquire SmartEquine®, suggest Covetrus is focusing on core veterinary technology services while divesting certain business units. This creates potential sales avenues for products and services aligned with their core focus on practice improvement and patient care enhancement.

Growth in Innovation Cresilon’s partnership to distribute VETIGEL® across Europe indicates a commitment to adopting innovative, plant-based medical products. Opportunities exist to present new veterinary medical devices, surgical tools, or healthtech solutions that can complement Covetrus's mission to improve clinical outcomes.

Market Positioning Covetrus operates within a competitive market alongside companies like Merck Animal Health, Zoetis, and Vetsource, all focused on veterinary health solutions. There’s potential to target niche or emerging areas such as animal surgical technologies, data analytics, or veterinary practice management tools to strengthen their service portfolio.

Financial Accessibility With revenue estimates between $10M and $25M and recent private equity ownership, Covetrus appears open to strategic investments and innovative solutions to support growth. Sales efforts can focus on scalable, cost-effective technologies and services that demonstrate clear value and align with their growth and efficiency objectives.